Literature DB >> 8880115

Electrostatic charge on a plastic spacer device influences the delivery of salbutamol.

J H Wildhaber1, S G Devadason, M J Hayden, R James, A P Dufty, R A Fox, Q A Summers, P N LeSouëf.   

Abstract

The aim of this study was to determine whether electrostatic charge on a plastic spacer decreases the delivery of salbutamol from a pressurized metered-dose inhaler (pMDI) and, if so, to find an optimal and practical treatment to remove the charge. Ten single actuations from a salbutamol pMDI were drawn through different Volumatic spacers at a constant flow of 60 L.min-1. The efficacies of different methods of removing charge were tested, including detergent coating of the spacers. A multistage liquid impinger was used to determine the particle size distribution of the output of the pMDI through the Volumatic spacers. The electrostatic charge on the inner surface of the spacers was measured both quantitatively with an electrometer, and qualitatively by the attraction of a thin strip of cellulose membrane to the wall of the spacer. Each experiment was repeated four times. Ionic detergent coating of the spacers removed the charge for at least 24 h. This resulted in an increase of 55-70% in small particle (< 6.8 microns) delivery compared to delivery from new spacers with high charge. We have demonstrated that electrostatic charge plays a major role in the delivery of salbutamol through plastic spacers. Adequate treatment with ionic detergent removes the charge and improves drug delivery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880115     DOI: 10.1183/09031936.96.09091943

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Reducing electrostatic charge on spacer devices and bronchodilator response.

Authors:  J H Wildhaber; G W Waterer; G L Hall; Q A Summers
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

2.  Effect of plastic spacer handling on salbutamol lung deposition in asthmatic children.

Authors:  Brian J Lipworth; Daniel K C Lee; Jacob Anhøj; Hans Bisgaard
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

3.  Aerosol profile extracted from spacers as a determinant of actual dose.

Authors:  Sylvia Verbanck; Chris Vervaet; Daniël Schuermans; Walter Vincken
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

4.  Randomised controlled trial of the efficacy of a metered dose inhaler with bottle spacer for bronchodilator treatment in acute lower airway obstruction.

Authors:  H J Zar; S Streun; M Levin; E G Weinberg; G H Swingler
Journal:  Arch Dis Child       Date:  2006-08-11       Impact factor: 3.791

Review 5.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

6.  Response to albuterol MDI delivered through an anti-static chamber during nocturnal bronchospasm.

Authors:  Sreekala Prabhakaran; Jonathan Shuster; Sarah Chesrown; Leslie Hendeles
Journal:  Respir Care       Date:  2012-02-17       Impact factor: 2.258

7.  Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children.

Authors:  J Anhøj; H Bisgaard; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

8.  A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices.

Authors:  P W Barry; C O'callaghan
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 9.  Use of inhaler devices in pediatric asthma.

Authors:  Fernando Maria De Benedictis; David Selvaggio
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding Chambers.

Authors:  Fanak Fahimi; Farzad Kobarfard; Jamshid Salamzadeh; Atefeh Fakharian; Pegah Abdolahi; Azita Hajhossein Talasaz; Hamid Mahboobi Pour; Shadi Baniasadi; Mohammadreza Masjedi
Journal:  World Allergy Organ J       Date:  2011-11-18       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.